An external FDA advisory panel voted to allow specialized pharmacies to produce and sell four previously banned peptide treatments.
Most individuals with childhood-onset arthritis demonstrate a strong interest in continuing to participate in research studies as adults.
Nonserious infection risk in rheumatoid arthritis is similar across treatment classes after adjustment for clinical and seasonal factors.
Higher Life’s Essential 8 scores are associated with a lower risk for developing knee, hand, and hip osteoarthritis.
Opioid prescribing trends decreased between 2010 and 2024, with variations observed across duration of use and prescriber specialty.
Vunakizumab therapy provides rapid and sustained improvements in disease symptoms, physical function, and spinal mobility in patients with active radiographic axial spondyloarthritis. Vunakizumab ...
Because of its heterogenous presentation, Sjögren disease is commonly misdiagnosed, leading to delays in treatment ...
Patients presenting to the emergency department for gout flares face low rates of follow-up care and frequent repeat visits after discharge.
Recombinant zoster vaccine is highly effective and safe for patients with inflammatory rheumatic diseases receiving immunosuppressive therapies.
Measures of pain-related interpretation bias reflect a shared underlying construct in adults with chronic pain.
Obinutuzumab beta, particularly at a dose of 1000 mg every 6 months, may improve renal response in patients with lupus nephritis already receiving standard therapies. Obinutuzumab beta dosed at 1000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results